Overview of Private Equity in U.S. Health Care The U.S. health care industry stands at a critical juncture, grappling with a staggering $104 billion in private equity (PE) investments as of this year, a dramatic rise from just $5 billion at the turn of the century. This influx of capital has
As the open enrollment period for the Affordable Care Act (ACA) marketplaces kicked off on November 1 across most states, a cloud of uncertainty hangs over the more than 24 million Americans who rely on these platforms for health insurance. The core issue fueling this confusion is the potential
I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert specializing in medical technology. With a deep background in the manufacturing of medical devices for diagnostics and treatment, Faisal has been at the forefront of driving innovation in healthcare. Today, we’re diving i
Setting the Stage for a Market Showdown The obesity drug market, a rapidly expanding sector valued at billions, has become the battleground for a fierce corporate rivalry between pharmaceutical giants Pfizer and Novo Nordisk. With global demand for GLP-1 agonists—drugs targeting weight loss and m
Understanding the Role of Pharmacy Benefit Managers (PBMs) in California In California’s complex healthcare landscape, a staggering number of patients and pharmacies find themselves navigating a system heavily influenced by pharmacy benefit managers (PBMs), intermediaries that control prescription d
As the open enrollment period for the Affordable Care Act (ACA) marketplace kicks off, millions of Americans are grappling with a harsh reality: healthcare premiums are skyrocketing due to the looming expiration of critical tax credit subsidies. For the roughly 24 million individuals who rely on
